- Contact Us
Thanks to support from companies in the health care industry, the 2023 AANP National Conference is able to offer complimentary access to non-CE Product Theaters (PTs) for registered conference attendees. PTs are educational presentations, which may be branded and are usually sponsored using marketing funds from health care industry companies.
The occurrence of these PTs and the presentation of industry sponsored information at the 2023 AANP National Conference does not constitute an AANP product endorsement.
Regulations and Restrictions
Some states have passed regulations requiring the industry to track and report the value of gifts to health care providers from industry marketing and have also placed restrictions on certain employment settings. In obeying these state regulations and restrictions, the sponsor may choose at their discretion to restrict access to health care provider attendees from specific states. Their reports must contain the value of each meal and the recipient's name and contact information. By attending a PT, you are providing permission for AANP to release your contact information (name, mailing address, phone number, email address and other information as requested) to the event sponsor and their organizing company for the purpose of meeting various state reporting requirements and sending attendees related event product updates.
AANP will assist in notifying registered conference attendees from the states or employment settings that are not eligible to attend PTs if information regarding restrictions is provided by the sponsor. The sponsor's signage will also be featured near the event entrance, indicating any states and employment settings restricted from attending the industry sponsored non-CE PT event.
Registration and Admission
Due to their educational focus, attendance is limited. Restrictions apply. PTs are only open to registered conference attendees. Registration and admission will occur at the entrance of each scheduled event on a first come, first served basis. You must have your conference name badge with you to be scanned for admission. There will be no pre-registration.
23.2.055 Hepatitis: Nurse Practitioners Absolutely Hold the Key to Prevention
23.2.056 Don't Wait Learn More About Otezla® (apremilast)
23.2.057 When Hypothyroid Patients Speak, Are We Listening? An Expert Discussion on Patient Preference and Satisfaction
23.2.058 Using Behavioral Science to Help Understand and Address Vaccine-Reluctant Patients
23.2.059 Learn More About an Oral Treatment Option for Adults with Schizophrenia and Bipolar Disorder
23.2.130 The FLU Ends With U. Are YOU Prepared for the Upcoming Influenza Season?
23.2.131 New Understanding of Vasomotor Symptoms Due to Menopause: Exploring the Evidence
23.2.132 Journey to an Axial Spondyloarthritis Diagnosis: An Overview and Case-Based Study Discussion
23.3.001 Take Action Against Obesity: Do More Than Lifestyle Modifications
23.3.002 Thriving Through Transformation: NP Experts Discuss the Complex Contraceptive Needs of the 40+ Woman
23.3.003 Partner in Asthma Care, Partner in Asthma Relief
23.3.079 Beyond the Rash: Examining the Burden of Herpes Zoster in High-risk Populations
23.3.080 Is LEQVIO® (inclisiran) an Attractive Therapy? What Makes It Different?
23.3.081 FreeStyle Libre Systems and Conquering the Gap in Diabetes Care with CGM
23.3.082 Reframing Rescue Therapy to Help Prevent Asthma Exacerbations
23.3.083 Review of an Oral COVID-19 Treatment Option From Pfizer.
23.4.001 Demystifying Testosterone Replacement Therapies
23.4.002 Identifying People at Risk for HIV Who May Benefit From PrEP Medication
23.4.049 Uncomplicated UTIs: Empowering NPs to Tackle the Common Condition
23.4.050 Optimizing Patient Care in Parkinson's Disease: Individualized Dosing and the Critical Role of the NP
23.4.051 Clinical Insights in CAD and/or PAD: Reducing the Risk of Major Cardiovascular and Major Thrombotic Vascular Events
23.4.052 The Impact of Tardive Dyskinesia: The Data and a Patient Story
23.4.053 Mounjaro™ (tirzepatide) Product Theater
23.4.055 Nurtec ODT 75 mg Industry Sponsored Non-CE Product Theater. Learn About a Medication That Can Treat and Prevent Migraines
23.4.109 Moving Beyond HbA1c: New Standards for Assessing Glycemic Control
23.4.110 Join Exact Sciences for a Presentation on the Benefits of CRC Screening With Cologuard®
23.5.001 THE STORY BELOW Alkaline Phosphatase (ALP) and Its Role in Hypophosphatasia (HPP)
23.5.002 Repatha® Added to a Statin Can Dramatically Lower LDL-C and Reduce the Risk of Another MI, Stroke or Coronary Revascularization
23.5.060 Redefining the Treatment of Insomnia.
23.5.061 One of a Kind - The Value of Individualized Treatment for Patients with Endometriosis
23.5.062 Guide to the IBS Guidelines: Comparing and Contrasting ACG and AGA Recommendations
23.5.063 PrEP Today. Data Discussions on an HIV-1 PrEP Option
23.5.064 Novel Diagnostic for Hyper Thyroid Patients with A.I.T.D.